Follow The Filings

BFLY Butterfly Network Inc.

Health Care, filed as BUTTERFLY NETWORK INC (COM CL A), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 3 Owners
  • Max 2.2%
  • $168M
  • 1 add 1 small

In 2026 Q2 Polen Capital Management added to Butterfly Network.

Who owns this now

Largest portfolio weights among holders, up to 2.2% (Glenview Capital Management). Not free-float ownership.

  1. Glenview Capital Management 2.2%
  2. Cathie Wood Reduce 0.28%
  3. Polen Capital Management Add 0.03%

Who owns BFLY

Sorted by value, long equity only, as of 2026 Q2.

History
Glenview Capital Management 2.2% Hold 14,335,055 $121M History
Cathie Wood, Ark Investment Management 0.28% Small trim −2.7% 5,085,456 $43M History
Polen Capital Management 0.03%, was <0.01% Add +18.3% 480,502 $4M History

3 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by BFLY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BFLY insider trades
  • $13.1M bought by 2 insiders
  • $37.7M sold by 4 insiders outside a trading plan
  • $78.4M sold by 3 insiders under 10b5-1 plans
  1. Joseph Devivo CEO
    Planned sale
    $359K 35,790 shares at $10.02 0.5% of stake
    Traded Oct 6 Filed Oct 8
    ↗
  2. Joseph Devivo CEO
    Planned sale
    $60K 5,980 shares at $10.01 0.1% of stake
    Traded Sep 22–23 Filed Sep 24
    ↗
  3. S. Louise Phanstiel Director
    Buy
    $1M 115,200 shares at $8.68 +62% to stake
    Traded Aug 14 Filed Aug 17
    ↗
  4. Larry Robbins Director
    Sale
    $20.6M 2,297,733 shares at $8.98 44% of stake
    Traded Aug 13–17 Filed Aug 17
    ↗
  5. Nicholas Caezza Deputy General Counsel
    Sale
    $98K 10,000 shares at $9.75 3.2% of stake
    Traded Aug 11 Filed Aug 12
    ↗
  6. Joseph Devivo CEO
    Planned sale
    $684K 68,346 shares at $10.01 0.9% of stake
    Traded Aug 10 Filed Aug 12
    ↗
  7. Megan Carlson CAO and SVP, Finance
    Sale
    $541K 68,852 shares at $7.86 14% of stake
    Traded Jul 31 Filed Aug 4
    ↗
  8. Larry Robbins Director
    Sale
    $14M 1,876,292 shares at $7.45 13% of stake
    Traded Jul 31–Aug 3 Filed Aug 3
    ↗
  9. Jonathan M Rothberg Director
    Planned sale
    $4.3M 659,913 shares at $6.47 100% of stake
    Traded Jul 22 Filed Jul 24
    ↗
  10. Jonathan M Rothberg Director
    Planned sale
    $20.7M 3,126,453 shares at $6.64 86% of stake
    Traded Jul 17–21 Filed Jul 21
    ↗
  11. Jonathan M Rothberg Director
    Planned sale
    $29.4M 4,013,452 shares at $7.32
    Traded Jul 14–16 Filed Jul 16
    ↗
  12. Steve Cashman Chief Business Officer
    Sale
    $1.9M 399,461 shares at $4.74 20% of stake
    Traded Jun 5–8 Filed Jun 9
    ↗
  13. Megan Carlson CAO and SVP, Finance
    Sale
    $524K 110,422 shares at $4.75 18% of stake
    Traded May 1 Filed May 5
    ↗
  14. Steve Cashman Chief Business Officer
    Planned sale
    $1M 200,000 shares at $5.22 8.4% of stake
    Traded Apr 16 Filed Apr 17
    ↗
  15. Steve Cashman Chief Business Officer
    Planned sale
    $1.1M 250,000 shares at $4.35 12% of stake
    Traded Feb 26 Filed Mar 2
    ↗

Also filed in the last 12 months, not counted as buying or selling: 22 sales to cover taxes, 16 stock grants, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $65.9M $82.06M $97.61M
Gross profit $16.86M $48.83M $45.73M
Gross margin * 25.6% 59.5% 46.9%
Net income -$133.7M -$72.49M -$77.06M
Net margin * -202.9% -88.3% -79.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $231.26M $192.61M $249.1M
Total non-current assets * $73.01M $63.47M $47.43M
Total assets $304.27M $256.08M $296.53M
Total current liabilities $44.27M $48.22M $65.12M
Total non-current liabilities * $39.95M $39.04M $35.44M
Total equity $220.05M $168.83M $195.98M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$98.82M -$41.71M -$12.7M
Cash from investing $70.41M -$2.66M -$3.35M
Cash from financing $0.228M -$1.5M $77.76M
Net change in cash -$28.18M -$45.86M $61.71M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.